Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Ixchiq
(VLA1553) /
Valneva
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
«
1
2
|
|||||||||
VLA1553
/
Valneva
Trial completion, Trial completion date:
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers
(clinicaltrials.gov) - Aug 29, 2019
P1
, N=120, Completed,
Sponsor: Valneva Austria GmbH
Active, not recruiting --> Completed | Trial completion date: Nov 2019 --> Jul 2019
|
|||||||||
VLA1553
/
Valneva
Trial completion date:
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers
(clinicaltrials.gov) - Jan 24, 2019
P1
, N=120, Active, not recruiting,
Sponsor: Valneva Austria GmbH
Active, not recruiting --> Completed | Trial completion date: Nov 2019 --> Jul 2019 Trial completion date: Jun 2019 --> Nov 2019
|
|||||||||
VLA1553
/
Valneva
Enrollment closed:
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers
(clinicaltrials.gov) - Aug 1, 2018
P1
, N=120, Active, not recruiting,
Sponsor: Valneva Austria GmbH
Trial completion date: Jun 2019 --> Nov 2019 Recruiting --> Active, not recruiting
|||
|||||||
VLA1553
/
Valneva
Enrollment open:
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers
(clinicaltrials.gov) - Mar 15, 2018
P1
, N=120, Recruiting,
Sponsor: Valneva Austria GmbH
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
|||
|||||||
VLA1553
/
Valneva
New P1 trial:
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers
(clinicaltrials.gov) - Dec 26, 2017
P1
, N=120, Not yet recruiting,
Sponsor: Valneva Austria GmbH